Bone Marrow TransplantationBone MarrowTransplantation, HomologousBone Marrow CellsGraft vs Host DiseaseHistocompatibilityHematopoietic Stem Cell TransplantationTissue DonorsHistocompatibility TestingTransplantation ConditioningLeukemiaHematologic NeoplasmsGraft SurvivalWhole-Body IrradiationTransplantation ChimeraHLA AntigensBone and BonesSevere Combined ImmunodeficiencyLymphocyte DepletionAnemia, AplasticTransplantation, AutologousHaploidyImmunosuppressive AgentsCytomegalovirus InfectionsGraft RejectionHaplotypesTreatment OutcomeHematopoietic Stem CellsLeukemia, Myeloid, AcuteRecurrenceT-LymphocytesLymphocyte TransfusionPrecursor Cell Lymphoblastic Leukemia-LymphomaPeripheral Blood Stem Cell TransplantationFetal TherapiesKidney TransplantationGraft vs Leukemia EffectBone Marrow DiseasesImmunocompromised HostBone Marrow ExaminationImmunosuppressionBone Marrow PurgingAntilymphocyte SerumOpportunistic InfectionsBone Marrow NeoplasmsCyclosporineTime FactorsRetrospective StudiesAcute DiseaseUnrelated DonorsLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLiving DonorsCyclophosphamideHematopoiesisCord Blood Stem Cell TransplantationMycosesMice, Inbred C57BLAntigens, CD34CytomegalovirusSiblingsBone RemodelingReceptors, KIRStem Cell TransplantationRadiation ChimeraBusulfanDisease-Free SurvivalTransplantsRemission InductionPneumonia, ViralFatal OutcomeTransplantation, IsogeneicColony-Forming Units AssaySurvival RateHematologic DiseasesGanciclovirMyeloablative AgonistsSurvival AnalysisN-Acetylgalactosamine-4-SulfataseKiller Cells, NaturalNuclear FamilyGraft vs Host ReactionGranulocyte Colony-Stimulating FactorCombined Modality TherapyFollow-Up StudiesMyelodysplastic SyndromesAspergillosisLeukemia, MyeloidHepatic Veno-Occlusive DiseaseCystitisBone DensityImmunotherapy, AdoptiveTransplantationBlood Group IncompatibilityCell DifferentiationLymphoma, Non-HodgkinPolymerase Chain ReactionMucormycosisPostoperative ComplicationsBone ResorptionLeukocyte Count